http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009522281-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-056
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708
filingDate 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009522281-A
titleOfInvention Treatment based on translational dysfunction
abstract Methods and compositions for inhibiting the eukaryotic translation initiation factor eIF4E are provided. Such methods and compositions may be used alone or in combination with other therapies for inhibiting cell proliferation and / or treating cancer, such as gene therapy.
priorityDate 2005-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004012769-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1010380-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005524662-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004509061-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004100995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005159372-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466979492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466778264

Total number of triples: 32.